Macitentan in daily clinical practice: A single centre, 1-year experience.

The effectiveness and safety of macitentan, a dual endothelin-receptor antagonist (ERA) approved for the treatment of pulmonary arterial hypertension (PAH), were shown in an extensive clinical trial oriented towards morbidity and mortality events. Our aim was to describe a single centre's experience of the utilization of macitentan in patients with PAH in clinical practice settings. Thirteen patients with different aetiologies and previous PAH treatments were studied. After 12 months of macitentan treatment, 11 patients improved their functional class (FC), all patients improved their 6-minute walk distance (6MWD) test, and 10 patients lowered their NT-proBNP plasma levels. Additionally, cardiac imaging parameters were also improved. No cases resulted in hospitalization, septostomy, transplant or death.

Manejo de comunicaciones respiratorio-digestivas inusuales de origen neoplásico / No disponible

Las fístulas respiratorio-digestivas secundarias a procesos malignos broncogénicos son complicaciones infrecuentes que generan gran morbimortalidad, ensombreciendo el pronóstico de la neoplasia, más aún cuanto más se demora su diagnóstico. A continuación, describimos 2 casos con inusuales complicaciones de este tipo, el proceso de identificación y su manejo terapéutico. A pesar de la escasa evidencia disponible, se recomienda un abordaje multidisciplinar con un enfoque esencialmente paliativo y mediante técnicas endoscópicas, sobre todo, resolver de forma segura y duradera la disfagia, origen de fatales infecciones respiratorias, que se traducirá en una aceptable calidad de vida y una mayor supervivencia para estos pacientes

Respiratory-digestive fistulas secondary to malignant bronchogenic carcinomas are uncommon complications, which have high morbidity and mortality rates and worsen the prognosis of the neoplasm, particularly if their diagnosis is delayed. In this study we describe 2 cases of this rare complication, together with their identification process and therapeutic management. In spite of the scarce evidence available, a multidisciplinary approach is recommended, mainly with palliative management and through endoscopic techniques in order to achieve a safe and lasting correction of dysphagia, which is the cause of fatal respiratory infections. The treatment will lead to an acceptable quality of life and higher survival rates for these patients